Genetic variability of CYP2D6, CYP2C19, and CYP1A2 in patients with treatment resistance to antipsychotics and antidepressants
Folia Medica · 2025
DOI: 10.3897/folmed.67.e149527 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Medica, 2025. Verfasst von Tatiana A Zhiganova und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dynasty Medical Centers, Saint Petersburg, Russia. Hauptthemen laut MEDLINE: Antipsychotic Agents, Antidepressive Agents, Cytochrome P-450 CYP2C19, Cytochrome P-450 CYP2D6. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
The study objective was to assess the frequency of gene alleles responsible for the metabolism and elimination of drugs in treatment-resistant patients to antipsychotics and/or antidepressants. Materials and methods : The frequency of CYP2D6, CYP2C19, and CYP1A2 gene alleles was studied in 133 patients aged 18–70 years in comparison with a healthy population. Results : Patients with treatment resistance to antipsychotics and/or antidepressants demonstrated the increased allele frequency of CYP2D6 *3 (4.5% vs. 1.0%, OR 4.5, p =0.003), CYP2C19 *17 (24.4% vs. 15.4%, OR 1.78, p =0.027), CYP1A2 *1A (68.5% vs. 41.4%, OR 3.03, p <0.001), decreased allele frequency of CYP2C19 *1 (61.3% vs. 88.3%, OR 0.21, p <0.001) and CYP1A2 *1F (30.4% vs. 58.6%, p <0.001). The frequency of CYP2D6 *5 allele was higher in females (3.8% vs. 0% in males, OR 11.6, p =0.029). No age difference was found in CYP2D6, CYP2C19, and CYP1A2 alleles frequencies in the subgroups of patients aged 18–30 years versus 31–70 years.
Conclusion
The observed difference in the genotype prevalence of CYP2D6, CYP2C19, and CYP1A2 in patients with antipsychotic and/or antidepressant resistance allows us to recommend pharmacogenetic testing for routine clinical practice in order to select the most effective and safe treatment for patients with antipsychotic and antidepressant resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dynasty Medical Centers, Saint Petersburg, Russia.
- OST-RUS, Saint Petersburg, Russia.
ORCID-Profile: Tatiana A Zhiganova, Evgenia A Radkova
Zitieren
APA
Zhiganova, T. A., & Radkova, E. A. (2025). Genetic variability of CYP2D6, CYP2C19, and CYP1A2 in patients with treatment resistance to antipsychotics and antidepressants. Folia Medica. https://doi.org/10.3897/folmed.67.e149527
Vancouver
Zhiganova TA, Radkova EA. Genetic variability of CYP2D6, CYP2C19, and CYP1A2 in patients with treatment resistance to antipsychotics and antidepressants. Folia Medica. 2025. doi:10.3897/folmed.67.e149527
BibTeX
@article{Zhiganova2025,
author = {Zhiganova, Tatiana A and Radkova, Evgenia A},
title = {Genetic variability of CYP2D6, CYP2C19, and CYP1A2 in patients with treatment resistance to antipsychotics and antidepressants},
journal = {Folia Medica},
year = {2025},
doi = {10.3897/folmed.67.e149527}
}
EUVIMED